-
-
-
-
-
-
-
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
-
-
-
-
-
-
-
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
-
-
-
-
-
-
-
Vivos Therapeutics raises $4.64 million from warrant exercises
-
-
-
-
-
-
-
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
-
-
-
-
-
-
-
Vivos Therapeutics (VVOS) highlights positive trial results for treatment of OSA with Daytime-Nighttime Appliance
-
-
-
-
-
-
-
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
-
-
-
-
-
-
-
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Conference Call
-
1,177,157 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

